A pit-1 threonine 220 phosphomimic reduces binding to monomeric DNA sites to inhibit ras and estrogen stimulation of the prolactin gene promoter

Molecular Endocrinology

Volumn 24, Issue 1, 2010, Pages 91-103

  Jean, Annie ^a   Gutierrez Hartmann, Arthur ^a   Duval, Dawn L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARTIC ACID; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIMER; DNA; ESTROGEN; ESTROGEN RECEPTOR; HOMEODOMAIN PROTEIN; MONOMER; PROLACTIN; PROTEIN KINASE C; SERINE; THREONINE; TRANSCRIPTION FACTOR PIT 1;

ARTICLE; CELL CYCLE; DNA BINDING; DNA TRANSCRIPTION; FEMALE; HUMAN; HUMAN CELL; HYPOPHYSIS; MUTATION; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; WILD TYPE;

ANIMALS; ASPARTIC ACID; CELL LINE; DNA-BINDING PROTEINS; ESTRADIOL; HELA CELLS; HUMANS; MUTANT PROTEINS; MUTATION; ONCOGENE PROTEIN P21(RAS); PHOSPHORYLATION; PROLACTIN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEIN C-ETS-1; RATS; RECOMBINANT FUSION PROTEINS; RESPONSE ELEMENTS; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

RATTUS;

EID: 73549112877     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0279     Document Type: Article

References (59)

1. Bach I, Rhodes SJ, Pearse II RV, Heinzel T, Gloss B, Scully KM, Sawchenko PE, Rosenfeld MG 1995 P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci USA 92:2720-2724
2. Bradford AP, Brodsky KS, Diamond SE, Kuhn LC, Liu Y, Gutierrez-Hartmann A 2000 The Pit-1 homeodomain and α-domain interact with Ets-1 and modulate synergistic activation of the rat prolactin promoter. J Biol Chem 275:3100-3106
3. Dasen JS, O'Connell SM, Flynn SE, Treier, Gleiberman AS, Szeto DP, Hooshmand F, Aggarwal AK, Rosenfeld MG 1999 Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 97:587-598
4. Day RN, Koike S, Sakai M, Muramatsu M, Maurer RA 1990 Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol Endocrinol 4:1964-1971
5. Gordon DF, Woodmansee WW, Black JN, Dowding JM, Bendrick-Peart J, Wood WM, Ridgway EC 2002 Domains of Pit-1 required for transcriptional synergy with GATA-2 on the TSHα gene. Mol Cell Endocrinol 196:53-66
6. Gordon DF, Lewis SR, Haugen BR, James RA, McDermott MT, Wood WM, Ridgway EC 1997 Pit-1 and GATA-2 interact and functionally cooperate to activate the thyrotropin β-subunit promoter. J Biol Chem 272:24339-24347
7. Holloway JM, Szeto DP, Scully KM, Glass CK, Rosenfeld MG 1995 Pit-1 binding to specific DNA sites as a monomer of dimer determines gene-specific use of a tyrosine-dependent synergy domain. Genes Dev 9:1992-2006
8. Jacob KK, Stanley FM 2001 Elk-1, C/EBPα, and Pit-1 confer an insulin-responsive phenotype on prolactin promoter expression in Chinese hamster ovary cells and define the factors required for insulin-increased transcription. J Biol Chem 276:24931-24936
9. Lira SA, Kalla KA, Glass CK, Drolet DW, Rosenfeld MG 1993 Synergistic interactions between Pit-1 and other elements are required for effective somatotroph rat growth hormone gene expression in transgenic mice. Mol Endocrinol 7:694-701
10. Sánchez-Pacheco A, Peña P, Palomino P, Güell A, Castrillo JL, Aranda A 1998 The transcription factor GHF-1, but not the splicevariant GHF-2, cooperates with thyroid hormone and retinoic acid receptors to stimulate rat growth hormone gene expression. FEBS Lett 422:103-107
11. Schaufele F, West BL, Baxter JD 1992 Synergistic activation of the rat growth hormone promoter by Pit-1 and the thyroid hormone receptor. Mol Endocrinol 6:656-665
12. Steinfelder HJ, Hauser P, Nakayama Y, Radovick S, McClaskey JH, Taylor T, Weintraub BD, Wondisford FE 1991 Thyrotropin-releasing hormone regulation of human TSHB expression: role of a pituitary-specific transcription factor (Pit-1/GHF-1) and potential interaction with a thyroid hormone-inhibitory element. Proc Natl Acad Sci USA 88:3130-3134
13. Szeto DP, Ryan AK, O'Connell SM, Rosenfeld MG 1996 P-OTX: A Pit-1-interacting homeodomain factor expressed during anterior pituitary gland development. Proc Natl Acad Sci USA 93:7706-7710
14. Tremblay JJ, Lanctôt C, Drouin J 1998 The pan-pituitary activator of transcription, Ptx-1, acts in synergy with SF-1 and Pit-1 and is an upstream regulator of the Lim-homeodomain gene Lim-3/Lhx-3. Mol Endocrinol 12:428-441
15. Voss JW, Wilson L, Rosenfeld MG 1991 POU-domain proteins Pit-1 and Oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter. Genes Dev 5:1309-1320
16. Xu L, Lavinsky RM, Dasen JS, Flynn SE, McInerney EM, Mullen TM, Heinzel T, Szeto D, Korzus E, Kurokawa R, Aggarwal AK, Rose DW, Glass CK, Rosenfeld MG 1998 Signal-specific co-activator domain requirements for Pit-1 activation. Nature 395:301-306
17. Wasylyk B, Hagman J, Gutierrez-Hartmann A 1998 Ets transcription factors: nuclear effectors of the Ras/MAP kinase signaling pathway. Trends Biochem Sci 23:213-216
18. Bradford AP, Conrad KE, Wasylyk C, Wasylyk B, Gutierrez-Hartmann A 1995 Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: Mapping of the essential c-Ets-1 domain. Mol Cell Biol 15:2849-2857
19. Bradford AP, Conrad KE, Tran PH, Ostrowski MC, Gutierrez-Hartmann A 1996 GHF-1/Pit-1 functions as a cell specific integrator of Ras signalling by targeting the Ras pathway to a composite Ets-1/GHF-1 response element. J Biol Chem 271:24639-24648
20. Bradford AP, Wasylyk C, Wasylyk B, Gutierrez-Hartmann A 1997 Interaction of Ets-1 and the POU-homeodomain GHF-1/Pit-1 reconstitutes pituitary specific gene expression. Mol Cell Biol 17:1065-1074
21. Schweppe RE, Frazer-Abel AA, Gutierrez-Hartmann A, Bradford AP 1997 Functional components of fibroblast growth factor signal transduction in pituitary cells. J Biol Chem272:30852-30859
22. Wasylyk C, Bradford AP, Gutierrez-Hartmann A, Wasylyk B 1997 Conserved mechanisms of Ras evolutionary related transcription factors, Ets-1 and pointed P2. Oncogene 14:899-913
23. Chang W, Zhou W, Theill LE, Baxter JD, Schaufele F 1996 An activation function of Pit-1 required selectively for synergistic transcription. J Biol Chem 271:17733-17738
24. Schaufele F 1996 CCAAT/enhancer-binding protein alpha activation of the rat growth hormone promoter in pituitary progenitor GHFT1-5 cells. J Biol Chem 271:21484-21489
25. Nowakowski BE, Maurer RA 1994 Multiple Pit-1 binding sites facilitate estrogen responsiveness of the prolactin gene. Mol Endocrinol 8:1742-1749
26. Rhodes SJ, Chen R, DiMattia GE, Scully KM, Kalla KA, Lin SC, Yu VC, Rosenfeld MG 1993 A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the Pit-1 gene. Genes Dev 7:913-932
27. Kim MK, McClaskey JH, Bodenner DL, Weintraub BD 1993 An AP-1-like factor and the pituitary-specific factor Pit-1 are both necessary to mediate hormonal induction of human thryotropin α gene expression. J Biol Chem 268:23366-23375
28. Farrow KN, Manning N, Schaufele F, Gutierrez-Hartmann A 1996 The c-Jun ë -domain inhibits neuroendocrine promoter activity in a DNA sequence- and pituitary-specific manner. J Biol Chem 271:17139-17146
29. Chuang FM, West BL, Baxter JD, Schaufele F 1997 Activities in Pit-1 determine whether receptor interacting protein 140 activates or inhibits Pit-1/nuclear receptor transcriptional synergy. Mol Endocrinol 11:1332-1341
30. Duval DL, Jean A, Gutierrez-Hartmann A 2003 Ras signaling and transcriptional synergy at a flexible Ets-1/Pit-1 composite DNA element is defined by the assembly of selective activation domains. J Biol Chem 278:39684-39696
31. Duval DL, Jonsen MD, Diamond SE, Murapa P, Jean A, Gutierrez-Hartmann A 2007 Differential utilization of transcription activation subdomains by distinct coactivators regulates Pit-1 basal and Ras responsiveness. Mol Endocrinol 21:172-185
32. Gordon DF, Tucker EA, Tundwal K, Hall H, Wood WM, Ridgway EC 2006 MED220/TRAP220 functions as a transcriptional coactivator with Pit-1 and GATA2 on the TSHβ promoter in thyrotropes. Mol Endocrinol 20:1073-1089
33. Schaufele F 1999 Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins. Mol Endocrinol 13:935-945
34. Rowan BG, Weigel NL, O'Malley BW 2000 Phosphorylation of steroid receptor coactivator-1. identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem 275:4475-4483
35. Goel A, Janknecht R 2004 Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu. J Biol Chem 279:14909-14916
36. Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Buggy Y, Young LS 2005 Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer. Clin Cancer Res 11:2111-2122
37. Conrad KE, Gutierrez-Hartmann A 1992 The ras and protein kinase A pathways are mutually antagonistic in regulating rat prolactin promoter activity. Oncogene 7:1279-1286
38. Oberwetter JM, Conrad KE, Gutierrez-Hartmann A 1993 The Ras and protein kinase C signaling pathways are functionally antagonistic in GH4 neuroendocrine cells. Mol Endocrinol 7:915-923
39. Kapiloff MS, Farkash Y, Wegner M, Rosenfeld MG 1991 Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science 253:786-789
40. Steinfelder HJ, Radovick S, Wondisford FE 1992 Hormonal regulation of the thyrotropin β-subunit gene by phosphorylation of the pituitary-specific transcription factor Pit-1. Proc Natl Acad Sci USA 89:5942-5945
41. Okimura Y, Howard PW, Maurer RA 1994 Pit-1 binding sites mediate transcriptional responses to cAMP through a mechanism which does not require inducible phosphorylation of Pit-1. Mol Endocrinol 8:1559-1565
42. Fischberg DJ, Chen XH, Bancroft C 1994 A Pit-1 phosphorylation mutant can mediate either basal or induced prolactin or growth hormone promoter activity. Mol Endocrinol 8:1566-1573
43. Roberts SB, Segil N, Heintz N 1991 Differential phosphorylation of the transcription factor Oct1 during the cell cycle. Science 253:1022-1026
44. Segil N, Roberts SB, Heintz N 1991 Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity. Science 254:1814-1816
45. Caelles C, Hennemann H, Karin M 1995 M-phase-specific phosphorylation of the POU transcription factor GHF-1 by a cell cycle-regulated protein kinase inhibits DNA binding. Mol Cell Biol 15:6694-6701
46. Augustijn KD, Duval DL, Wechselberger R, Kaptein R, Gutierrez-Hartmann A, van der Vliet PC 2002 Structural characterization of the PIT-1/ETS-1 interaction: PIT-1 phosphorylation regulates PIT-1/ETS-1 binding. Proc Natl Acad Sci USA 99:12657-12662
47. Shewchuk BM, Ho Y, Liebhaber SA, Cooke NE 2006 A single base difference between Pit-1 binding sites at the hGH promoter and locus control region specifies distinct Pit-1 conformations and functions. Mol Cell Biol 26:6535-6546
48. Liang J, Moye-Rowley S, Maurer RA 1995 In vivo mutational analysis of the DNA binding domain of the tissue-specific transcription factor, Pit-1. J Biol Chem 270:25520-25525
49. Jacobson EM, Li P, Leon-del-Rio A, Rosenfeld MG, Aggarwal AK 1997 Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. Genes Dev 11:198-212
50. Ingraham HA, Flynn SE, Voss JW, Albert VR, Kapiloff MS, Wilson L, Rosenfeld MG 1990 The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions. Cell 61:1021-1033
51. Häfner S, Adler HS, Mischak H, Janosch P, Heidecker G, Wolfman A, Pippig S, Lohse M, Ueffing M, Kolch W 1994 Mechanism of inhibition of Raf-1 by protein kinase A. Mol Cell Biol 14:6696-6703
52. Rajnarayan S, Chiono M, Alexander LM, Gutierrez-Hartmann A 1995 Reconstitution of protein kinase A regulation of the rat prolactin promoter in HeLa nonpituitary cells: identification of both GHF-1/Pit-1-dependent and -independent mechanisms. Mol Endocrinol 9:502-512
53. Phillips K, Luisi B 2000 The virtuoso of versatility: POU proteins that flex to fit. J Mol Biol 302:1023-1039
54. Zanger K, Radovick S, Wondisford FE 2001 CREB binding protein recruitment to the transcription complex requires growth factor-dependent phosphorylation of its GF box. Mol Cell 7:551-558
55. Cohen RN, Brue T, Naik K, Houlihan CA, Wondisford FE, Radovick S 2006 The role of CBP/p300 interactions and Pit-1 dimerization in the pathophysiological mechanism of combined pituitary hormone deficiency. J Clin Endocrinol Metab 91:239-247
56. Scully KM, Jacobson EM, Jepsen K, Lunyak V, Viadiu H, Carrière C, Rose DW, Hooshmand F, Aggarwal AK, Rosenfeld MG 2000 Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 290:1127-1131
57. Cohen LE, Zanger K, Brue T, Wondisford FE, Radovick S 1999 Defective retinoic acid regulation of the Pit-1 gene enhancer: a novel mechanism of combined pituitary hormone deficiency. Mol Endocrinol 13:476-484
58. Dignam JD, Lebovitz RM, Roeder RG 1983 Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489
59. Schweppe RE, Gutierrez-Hartmann A 2001 Pituitary Ets-1 and GABP bind to the growth factor regulatory sites of the rat prolactin promoter. Nucleic Acids Res 29:1251-1260